6.55

2.83% -0.17

Journey Medical Corp (DERM)

Overview News Price History Financials Discussions Forecast

Journey Medical Corp stock is traded at $6.55, with a volume of 181.49K. It is down -2.83% in the last 24 hours and down -8.80% over the past month. Journey Medical Corp is a commercial-stage pharmaceutical company that focuses on the selling and marketing of U.S. Food and Drug Administration (FDA) approved prescription pharmaceutical products for the treatment of dermatological conditions. Its current product portfolio includes FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. The company views its operations and manages its business in one segment, which reflects products for the treatment of dermatological conditions. The dermatological segment derives revenues from the sale of branded and authorized general prescription products that treat certain dermatological conditions.

Previous Close:

$6.72

Open:

$6.73

24h Volume:

181.49K

Relative Volume:

0.67

Market Cap:

$184.87M

Revenue:

$61.86M

Net Income/Loss:

$-11.43M

P/E Ratio:

-13.59

EPS:

-0.4818

Net Cash Flow:

$-12.52M

1W Performance:

+1.40%

1M Performance:

-8.80%

6M Performance:

-19.38%

1Y Performance:

-6.04%

1-Day Range:

$6.44

$6.81

1-Week Range:

$6.22

$7.64

52-Week Range:

$4.31

$9.555

Journey Medical Corp Stock (DERM) Company Profile

Name

Journey Medical Corp

Sector

Healthcare (1089)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

480-434-6670

Address

9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

DERM's Discussions on Twitter

Compare DERM vs TAK, TEVA, HLN, ZTS, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DERM Journey Medical Corp	6.55	189.67M	61.86M	-11.43M	-12.52M	-0.4818
TAK Takeda Pharmaceutical Co Adr	17.36	56.30B	29.91B	1.30B	3.49B	0.4056
TEVA Teva Pharmaceutical Industries Ltd Adr	36.49	42.85B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.5812	42.72B	14.54B	2.22B	2.58B	0.4871
ZTS Zoetis Inc	72.61	30.49B	9.51B	2.64B	2.14B	6.0361
UTHR United Therapeutics Corp	507.53	21.43B	3.17B	1.29B	1.01B	27.09

Journey Medical Corp Stock (DERM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-25-25	Initiated	H.C. Wainwright	Buy
Jul-30-25	Resumed	B. Riley Securities	Buy
Aug-22-24	Initiated	Rodman & Renshaw	Buy
Jun-28-24	Resumed	ROTH MKM	Buy
Dec-07-21	Initiated	B. Riley Securities	Buy

Journey Medical Corp Stock (DERM) Latest News

01:31 AM

FY2026 EPS Estimates for Journey Medical Lowered by Analyst - MarketBeat

01:31 AM

Aug 14, 2026

Teleconferência de Resultados do 2T26 da Journey Medical (FBIO): Receita cresce 23% com aceleração do Emrosi - TradingKey

Aug 14, 2026

Q3 EPS Estimates for Journey Medical Cut by HC Wainwright - MarketBeat

Aug 14, 2026

Conferencia de resultados del T2 de 2026 de Journey Medical (FBIO): los ingresos aumentan un 23% a medida que Emrosi se acelera - TradingKey

Aug 14, 2026

Journey Medical (FBIO) Q2 2026 Earnings Call: Revenue Rises 23% as Emrosi Accelerates - tradingkey.com

Aug 14, 2026

Journey Medical (DERM) Stock Eyes Break Even As Emrosi Gains Traction - Sahm

Aug 14, 2026

Aug 13, 2026

Analyst Reiterates Buy on Journey Medical as Emrosi Outperformance Supports Unchanged $13 Price Target - TipRanks

Aug 13, 2026

Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey - The Manila Times

Aug 13, 2026

Journey Medical's (DERM) Buy Rating Reaffirmed at B. Riley Financial - MarketBeat

Aug 13, 2026

Why is Journey Medical stock rallying today? - Investing.com

Aug 13, 2026

Why is Journey Medical stock rallying today? By Investing.com - Investing.com Canada

Aug 13, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Aug 13, 2026

Wasatch Advisors LP Buys 725,560 Shares of Journey Medical Corporation $DERM - MarketBeat

Aug 13, 2026